Intensity-modulated radiation therapy with simultaneous integrated boost technique following neoadjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma

Head and Neck

Volumn 31, Issue 9, 2009, Pages 1121-1128

  Kim, Kyubo ^a   Wu, Hong Gyun ^a,b   Hak, Jae Kim ^a   Sung, Myung Whun ^a   Kwang, Hyun Kim ^a   Lee, Se Hoon ^a   Dae, Seog Heo ^a   Hee, Jung Kim ^b   Charn, Il Park ^a,b  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Intensity modulated radiation therapy; Nasopharyngeal cancer; Neoadjuvant chemotherapy; Simultaneous integrated boost; Xerostomia

Indexed keywords

CISPLATIN; DOCETAXEL; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; PACLITAXEL;

ACUTE TOXICITY; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; ADVANCED CANCER; AGED; ANEMIA; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; COLLIMATOR; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LEUKOPENIA; LINEAR ACCELERATOR; MALE; MEDICAL INSTRUMENTATION; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NASOPHARYNX CARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT COMPLIANCE; PHARYNGITIS; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RADIATION INJURY; SURVIVAL RATE; THROMBOCYTOPENIA; TREATMENT OUTCOME; TREATMENT PLANNING; TUMOR VOLUME; XEROSTOMIA;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CENTRAL NERVOUS SYSTEM; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOADJUVANT THERAPY; RADIATION DOSAGE; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; YOUNG ADULT;

EID: 68549128880     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21076     Document Type: Article

References (23)

1. Marks JE, Bedwinek JM, Lee F, Purdy JA, Perez CA. Dose-response analysis for nasopharyngeal carcinoma: a historical perspective. Cancer 1982;50:1042-1050. (Pubitemid 12062879)
2. Baujat B, Audry H, Bourhis J, et al. Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients. Int J Radiat Oncol Biol Phys 2006;64:47-56. (Pubitemid 41831208)
3. Langendijk JA, Leemans CR, Buter J, Berkhof J, Slotman BJ. The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: a meta-analysis of the published literature. J Clin Oncol 2004;22:4604-4612. (Pubitemid 41185128)
4. Hong S, Wu HG, Chie EK, et al. Neoadjuvant chemotherapy and radiation therapy compared with radiation therapy alone in advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1999;45:901-905. (Pubitemid 29525453)
5. Al-Amro A, Al-Rajhi N, Khafaga Y, et al. Neoadjuvant chemotherapy followed by concurrent chemoradiation therapy in locally advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2005;62:508-513. (Pubitemid 40704469)
6. Yau TK, Lee AW, Wong DH, et al. Treatment of stage IV(A-B) nasopharyngeal carcinoma by induction-concurrent chemoradiotherapy and accelerated fractionation: impact of chemotherapy schemes. Int J Radiat Oncol Biol Phys 2006;66:1004-1010.
7. American Joint Committee on Cancer (AJCC). AJCC Cancer Staging Manual, 6th ed. New York: Springer-Verlag; 2002.
8. Mohan R, Wu Q, Manning M, Schmidt-Ullrich R. Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head and neck cancers. Int J Radiat Oncol Biol Phys 2000;46:619-630. (Pubitemid 30100639)
9. Chan AT, Ma BB, Lo YM, et al. Phase II study of neoadjuvant carboplatin and paclitaxel followed by radiotherapy and concurrent cisplatin in patients with locoregionally advanced nasopharyngeal carcinoma: therapeutic monitoring with plasma Epstein-Barr virus DNA. J Clin Oncol 2004;22:3053-3060.
10. Johnson FM, Garden A, Palmer JL, et al. A phase II study of docetaxel and carboplatin as neoadjuvant therapy for nasopharyngeal carcinoma with early T status and advanced N status. Cancer 2004;100:991-998. (Pubitemid 38222860)
11. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;31:1341-1346.
12. Kaplan EL, Meier PI. A nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
13. Commonterminology criteria for adverse events v3.0. Available at: http://ctep.cancer.gov/forms/CTCAEv3.pdf.
14. Lee N, Xia P, Quivey JM, et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys 2002;53:12-22. (Pubitemid 34465802)
15. Wolden SL, Chen WC, Pfister DG, et al. Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experience. Int J Radiat Oncol Biol Phys 2006;64:57-62. (Pubitemid 41831209)
16. Kwong DL, Sham JS, Leung LH, et al. Preliminary results of radiation dose escalation for locally advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2006;64:374-381. (Pubitemid 43083421)
17. Lee S, Back GM, Yi BY, et al. Preliminary results of a phase I/II study of simultaneous modulated accelerated radiotherapy for nondisseminated nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2006;65:152-160.
18. Wu S, Xie C, Jin X, Zhang P. Simultaneous modulated accelerated radiation therapy in the treatment of nasopharyngeal cancer: a local center's experience. Int J Radiat Oncol Biol Phys 2006;66(Suppl):S40-S46. (Pubitemid 44633549)
19. Lee NY, Harris J, Garden A, et al. Phase II multi-institutional study of IMRT ± chemotherapy for nasopharyngeal carcinoma (RTOG 0225): preliminary results. Int J Radiat Oncol Biol Phys 2007;69(Suppl.):S13.
20. Chan AT, Teo PM, Leung TW, et al. A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1995;33:569-577.
21. Chua DT, Sham JS, Choy D, et al. Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma: Asian-Oceanian Clinical Oncology Association Nasopharynx Cancer Study Group. Cancer 1998;83:2270-2283. (Pubitemid 28533496)
22. Ma J, Mai H, Hong M, et al. Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma. J Clin Oncol 2001;19:1350-1357. (Pubitemid 32202540)
23. Lee N, Chao KSC. Nasopharynx. In: Chao KSC, editor. Practical Essentials of Intensity Modulated Radiation Therapy, 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2005. pp 135-152.